申请人:Eli Lilly and Company
公开号:US05238959A1
公开(公告)日:1993-08-24
The present invention provides 3-(4-substitutedphenoxy)-3-phenyl propanamines capable of inhibiting the uptake of serotonin. These compounds are useful for treating many pharmacological disorders, including depression and obesity. These compounds can also be used to reduce the desire to smoke and consume alcohol.
本发明提供了能够抑制血清素摄取的3-(4-取代苯氧基)-3-苯基丙胺类化合物。这些化合物可用于治疗许多药理学紊乱,包括抑郁症和肥胖症。这些化合物还可以用于减少吸烟和饮酒的欲望。